Shares of eBay surge as Elliott Management reveals $1.4 billion stake, recommends portfolio review

Malaysia News News

Shares of eBay surge as Elliott Management reveals $1.4 billion stake, recommends portfolio review
Malaysia Latest News,Malaysia Headlines
  • 📰 CNBC
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 72%

Activist hedge fund Elliott Management announced a $1.4 billion stake in eBay in a letter to the e-commerce company's board on Tuesday.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stocks are 'cheap' and should surge to new highs this year: $6.6 billion money managerStocks are 'cheap' and should surge to new highs this year: $6.6 billion money manager$6.6 billion money manager calls stocks 'cheap,' predicts they'll surge to new highs this year
Read more »

Analysis | Citigroup is revealing pay gap data most companies don’t want to shareAnalysis | Citigroup is revealing pay gap data most companies don’t want to shareIt said women are paid nearly 30 percent less than men at the median globally, a figure that reveals a shortage of women in the top ranks and does not reflect pay discrepancies between men and women who work the same jobs.
Read more »

How to spot stocks that could blow up your portfolio during this earnings seasonHow to spot stocks that could blow up your portfolio during this earnings seasonAccording to AB Berstein, 'crowded' stocks tend to react very negatively to bad results. As widely traded stocks are usually priced for perfection, they are more vulnerable to surprises.
Read more »

Spectrum Pharma sells marketed portfolio for $160 million upfront, up to $140 million in milestone paymentsSpectrum Pharma sells marketed portfolio for $160 million upfront, up to $140 million in milestone paymentsSpectrum Pharmaceuticals Inc. said Thursday it has reached an agreement to sell its portfolio of seven FDA-approved hematology/oncology products to Acrotech Biopharma L.L.C. Spectrum said it will receive $160 million in an upfront cash payment and be entitled to up to $140 million milestone payments on reaching certain regulatory and sales goals. The company said its staff will be reduced by about 40% with most transitioning to Acrotech. The remaining staff will focus on the launch of it two late-stage pipeline treatments, ROLONTIS and poziotinib, which are cancer drugs. Shares were halted for the news, but have fallen 46.1% in the last 12 months, while the S&P 500 has fallen 6.7%.
Read more »



Render Time: 2025-02-27 04:21:10